Hi, I am Marmee Regine, your host in Pandemic Podcast Coronavirus. Merry Christmas to everyone. Today is the 9th episode where we will discuss part two of my podcast on the recent Presidential election in the USA during the coronavirus pandemic. In my past podcast episode, I mentioned Operation Warp Speed by President Donald Trump. Since the election, there has been foreign interference in our U.S. voting system by the so-called Dominion software manipulated outside the USA. There have been tons of hardcore video evidence showing this is a rigged election. Still, as usual, the media denies their existence despite several cases have reached the Supreme Court. To balance this episode with the first part, I will discuss more about the vaccine. Covid-19 vaccine information COVID-19 vaccine distribution began on December 14, 2020 Monday. It is the vaccine by Pfizer Inc and German partner BioNTech. In the Phase 3 study's first objective, the efficacy rate of 95% was exhibited among the tested subjects having no prior SARS-CoV-2 infection. The second objective revealed the same percentage to subjects who have no previous and with prior SARS-CoV-2 disease. Both cases were measured seven days after the second dose. The efficacy demonstrated consistency on variables such as age, gender, race, and ethnicity. Plus, all participants in the trial will be continuously monitored to estimate the period of safety and protection in a span of two years after their second dose. There was an estimate of 44,000 trial volunteers who committed to the Pfizer and BioNTech study. In return, both companies pledge always to prioritize their safety. The study participants ought to be commended for their courage to help in this pandemic time by using their physical bodies and immune system to advance this scientific breakthrough with regards to this E.U. authorization on COVID-19 vaccine where they are granted marketing authorization on a conditional level, emergency cases temporary approval from more than 40 countries. In the coming weeks, there are continuous regulatory reviews for further permissions in several countries.
About the Phase 3 Clinical Trial The Phase 3 clinical trial on BioNTech's proprietary mRNA technology, where the participants received their second dose, is in the ratio of 1:1 vaccine subjects to immune response, placebo effect, efficacy data for regulatory review. The study design is a randomized, observer-blinded study. The study will continue towards the prevention of infection by SARS-CoV-2, the virus that causes CO

UENI.com is the #1 solution for small businesses to get online and get discovered.

We provide them with a DONE-FOR-YOU website and Google profile to get their business online fast, easy, and with a professional look.

Link - https://ueni.sjv.io/15V3o9

 Website Hosting Services #MustBuyToday

The first-ever landing page builder optimized for conversions, sales, and bookings,
all under one roof. Experience the unfair advantage we give our users to grow their business with our free, 14-day trial. No credit card required.

https://booklikeaboss.sjv.io/e4Jyj1

Buzzsprout - Let's get your podcast launched!
Start for FREE

Allswell - Your Dream Bed Starts Here
Free delivery on your first order over $35.

Instacart - Groceries delivered in as little as 1 hour.
Free delivery on your first order over $35.

Disclaimer: This post contains affiliate links. If you make a purchase, I may receive a commission at no extra cost to you.

Support the show